KASSBERG THOMAS RICHARD 1303811 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-24 | 2023-10-23 | 2023-10-23 | 4 | Kassberg Thomas Richard | CBO & EVP | dsp | 39878.0 | 13.91 | 5.58 | 32.78 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 246860.0 | 71.49 (RARE) |
| 2023-10-24 | 2023-10-23 | 2023-10-23 | 4 | Kassberg Thomas Richard | CBO & EVP | acq | 39878.0 | 13.91 | 5.58 | 6.86 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code M | 286738.0 | 71.49 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Kassberg Thomas Richard | CBO & EVP | acq | 18757.0 | 7.06 | 2.28 | 0.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code A | 265617.0
|
82.11 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Kassberg Thomas Richard | CBO & EVP | dsp | 1285.0 | 0.48 | 0.16 | 53.75 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code F S | 264332.0
|
82.11 (RARE) |
| 2024-03-12 | 2024-03-11 | 2024-03-11 | 4 | Kassberg Thomas Richard | CBO & EVP | dsp | 11509.0 | 4.35 | 1.4 | 49.93 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 252823.0 | 82.11 (RARE) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-24 | 2023-10-23 | 2023-10-23 | 4 | Kassberg Thomas Richard | CBO & EVP | dsp | 39878.0 | 100.0 | 5.58 | 6.86 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code M | 0.0 | 71.49 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Kassberg Thomas Richard | CBO & EVP | acq | 31400.0 | 100.0 | 3.82 | 53.69 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code A | 31400.0 | 82.11 (RARE) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)